A Phase 2 Study of Depsipeptide in Relapsed/Refractory Multiple Myeloma
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Romidepsin (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 09 Sep 2005 New trial record.